文献速递治疗药物监测与药物基因组学

他克莫司群体药代动力学参数对剂量时间与吸收率假设的敏感性

Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real-world data and simulated data.
PubMed 文献 · Br J Clin Pharmacol · 2022-01-27

本研究基于363名受试者的电子健康记录数据,构建他克莫司群体药代动力学模型,评估剂量时间假设和吸收速率常数假设对参数估计的敏感性。结果显示,采用假设的末次给药时间与自然语言处理提取的末次给药时间所得参数估计无显著差异,且在一系列假设吸收速率常数下参数估计差异很小。模拟研究提示,消除较慢(半衰期较长)的药物对剂量时间误差不敏感,仅允许谷浓度采样的实验设计通常对吸收速率偏差不敏感。

要点

  • 他克莫司群体药代动力学参数对末次给药时间假设与提取值之间无显著差异。
  • 固定吸收速率常数与假设不同吸收速率常数对他克莫司参数估计影响很小。
  • 消除慢的药物对剂量时间误差不敏感,仅谷浓度设计对吸收速率偏差不敏感。

核心结论

  • 他克莫司群体药代动力学参数估计对末次给药时间假设和吸收速率常数假设不敏感。

研究设计与样本

  • 基于电子健康记录数据的群体药代动力学研究,纳入363名受试者,使用自动化系统EHR2PKPD构建数据集。
  • 采用自然语言处理系统medExtractR提取末次给药时间,并开展模拟研究评估药物特征和实验设计对敏感性的影响。

主要发现

  • 假设末次给药时间与提取的末次给药时间相比,参数估计无显著差异。
  • 在一系列假设吸收速率常数下,参数估计差异很小。
  • 模拟研究显示,消除较慢(半衰期较长)的药物对剂量时间误差不敏感。
  • 仅允许谷浓度采样的实验设计通常对吸收速率偏差不敏感。

临床怎么用

  • 利用电子健康记录数据估算他克莫司群体药代动力学参数时,可接受常规给药时间假设而无需精确给药时间。
  • 在仅采集谷浓度的治疗药物监测设计中,固定吸收速率常数对参数估计影响有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Use of electronic health record (EHR) data to estimate population pharmacokinetic (PK) profiles necessitates several assumptions. We sought to investigate sensitivity to some of these assumptions about dose timing and absorption rates. METHODS: A population PK study with 363 subjects was performed using real-world data extracted from EHRs to estimate the tacrolimus population PK profile. Data were extracted and built using our automated system, EHR2PKPD, suitable for quickly constructing large PK datasets from the EHR. Population PK studies for oral medications performed using EHR data often assume a regular dosing schedule as prescribed without incorporating exact dosing time. We assessed the sensitivity of the PK parameter estimates to assumptions about dose timing using last-dose times extracted by our own natural language processing system, medExtractR. We also investigated the sensitivity of estimates to absorption rate constants that are often fixed at a published value in tacrolimus population PK analyses. We conducted simulation studies to investigate how drug PK profiles and experimental designs such as concentration measurements design affect sensitivity to incorrect assumptions about dose timing and absorption rates. RESULTS: There was no appreciable difference in parameter estimates with assumed versus extracted last-dose time, and our sensitivity analysis revealed little difference between parameters estimated across a range of assumed absorption rate constants. CONCLUSION: Our findings suggest that drugs with a slower elimination rate (or a longer half-life) are less sensitive to dose timing errors and that experimental designs which only allow for trough blood concentrations are usually insensitive to deviation in absorption rate.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Williams ML, Weeks HL, Beck C, et al. Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real-world data and simulated data. Br J Clin Pharmacol. 2022. PMID: 34997625. doi:10.1111/bcp.15218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。